J Physiol Editor in Chief
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on August 8, 2003.
Copyright © 2003 by The Physiological Society
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
552/2/571    most recent
jphysiol.2003.049122v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Owyang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Owyang, C.

Received June 11, 2003
Revised July 11, 2003
Accepted after revision August 7, 2003

Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat

Ying Li1*, Xiao Yin Wu1, Jin Xia Zhu1, Jin Yan1, and Chung Owyang1

1 University of Michigan, 6510 Medical Sci Research Bldg 1

* To whom correspondence should be addressed. E-mail: yli{at}umich.edu.

The vago-vagal reflex plays an important role in mediating pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent luminal factors. We hypothesize that the vago-vagal reflex mediating pancreatic secretion in the rat is under central control and regulated by cholinergic pathways in the hypothalamus. To test this hypothesis, we demonstrated that chronic decerebration decreased basal pancreatic enzyme secretion from 318 ± 12 to 233 ± 9 mg h - 1 and reduced the net increase in pancreatic secretion stimulated by intraduodenal infusion of 5% peptone and hypertonic NaCl by 54% and 45%, respectively. Intracerebroventricular administration of methscopolamine (MSCP, 50 nmol/5 µ l), a blood brain barrier impermeant cholinergic muscarinic receptor antagonist, evoked similar results to those achieved by chronic decerebration. To localize the sites of action, we demonstrated that microinjection of MSCP (20 nmol) into the lateral hypothalamic nucleus and paraventricular nucleus resulted in inhibition of basal pancreatic secretion and luminally stimulated pancreatic protein secretion by 48% and 52%, respectively. Intracerebroventricular injection of hemicholinium-3 at doses known to deplete the endogenous ACh store produced similar inhibitory results. In addition, microinjection of ACh (5 pmol) or the muscarinic M1 receptor agonist McN-A-343 (30 ng) into the lateral hypothalamic nucleus increased pancreatic secretion over basal by 46% and 40%, respectively. Selectively lesion of lateral septal (LS) cholinergic neurons decreased basal pancreatic secretion and inhibited peptone-induced pancreatic secretion by 30%. Destroying of the lateral parabrachial nucleus (LPBN) produced a 44% inhibition of peptone- induced pancreatic section. Finally, microinjection of glutamate into the LS or the LPBN stimulated vagal pancreatic efferent nerve firings from basal 0 ± 0.5 to 4.5 ± 0.5 and 14 ± 2 impulses 30 s-1, respectively, and caused 50% and 84% increases of pancreatic protein output over basal, effects were eliminated by PVN administration of MSCP. These observations suggest that LS and LPBN cholinergic neurons regulate pancreatic secretions. LPBN cholinergic input to the hypothalamus plays a major role in the modulation of vagal pancreatic efferent nerve activity and pancreatic secretion evoked by vago-vagal reflex.


Key words: Cholinergic • Hypothalamus • Pancreas







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 The Physiological Society.